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Abstract 20 
Purpose: To evaluate the effectiveness between cold water immersion (CWI) and phase change 21 
material (PCM) cooling on intramuscular, core and skin temperature and cardiovascular 22 
responses.  23 
Methods: In a randomized, crossover design, 11 males completed 15 min of 15°C CWI to the 24 
umbilicus and 2 h recovery or 3 h of 15°C PCM covering the quadriceps and 1 h of recovery, 25 
separated by 24 h. Vastus lateralis intramuscular temperature at 1 and 3 cm, core and skin 26 
temperature, heart rate variability and thermal comfort were recorded at baseline, and 15 min 27 
intervals throughout treatment and recovery.  28 
Results: Intramuscular temperature decreased (P<0.001) during and after both treatments. A 29 
faster initial effect was observed from 15 min of CWI (Δ: 4.3±1.7°C 1 cm; 5.5±2.1°C 3 cm; 30 
P=0.01). However, over time (2 h 15 min), greater effects were observed from prolonged PCM 31 
treatment (Δ: 4.2±1.9°C 1 cm; 2.2±2.2°C 3 cm; treatment × time P=0.0001). During the first 32 
hour of recovery from both treatments, intramuscular temperature was higher from CWI at 1 cm 33 
(P=0.013) but not 3 cm. Core temperature deceased 0.25±0.32 from CWI (P=0.001) and 34 
0.28±0.27°C from PCM (P=0.0001) while heart rate variability increased during both treatments 35 
(P=0.001), with no differences between treatments.  36 
Conclusions: The magnitude of temperature reduction from CWI was comparable to PCM but 37 
intramuscular temperature was decreased for longer during PCM. Utilizing PCM cooling packs 38 
offers an alternative for delivering prolonged cooling whenever application of CWI is 39 
impractical while also exerting a central effect on core temperature and heart rate.  40 
Keywords: cryotherapy; recovery; thermoregulation; cooling  41 
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Introduction 42 
Cold water immersion (CWI) is a popular intervention utilized to facilitate recovery and 43 
improve function in the days following strenuous exercise. Two comprehensive reviews on CWI 44 
indicate some effectiveness at reducing soreness but inconclusive effects on other measures of 45 
recovery.1,2 Since typical CWI protocols involve a single post-exercise treatment for 10-15 min 46 
in water temperatures between 10-15°C,1,2 limited effectiveness might be a result of inadequate 47 
treatment temperature, duration, or a combination of the two. Low immersion temperatures may 48 
decrease tissue temperatures at a rate that may lead to excessive thermal stress and, if prolonged, 49 
are not well tolerated3 and are limited by individual thermal discomfort and risk of cold-related 50 
injury.4 Further, in practice, repeat treatments are impractical and present logistical challenges, 51 
but may be necessary if the goal is to decrease muscle5 and core6 temperature.  52 
A longer duration of targeted post-exercise cooling can be provided using temperature 53 
controlled phase change material (PCM), whereby PCM packs are placed over specific muscle 54 
groups and worn inside of garments to hold them in place. From a practical perspective, this 55 
cryotherapy modality offers an attractive alternative to CWI as individuals can resume activities 56 
of daily living while simultaneously receiving cryotherapy treatment that maintains a constant 57 
temperature for an extended duration. A 6 h PCM application reduced pain and strength loss on 58 
the days after eccentric quadriceps exercise in recreational athletes.7 A 3 h PCM application after 59 
a professional soccer match also reduced pain and strength loss on subsequent days.8 In these 60 
studies,7,8 participant thermal comfort was maintained while PCM packs were worn inside 61 
compression shorts and maintained a constant temperature of 15°C for at least 3 h before 62 
melting. 63 
CWI has been shown to reduce muscle temperature,9-12 core temperature,6,13,14 and 64 
increase heart rate variability (HRV).15-17 CWI is purported to enhance recovery following 65 
exercise primarily due to its ability to reduce tissue temperature and blood flow. Since the 66 
mechanism through which CWI is thought to be effective is through its anti-inflammatory 67 
effects,18 prolonging the duration of physiological cooling in order to attenuate metabolic 68 
processes in tissues, slow the up-regulation of cytokines and myokines, and reduce the 69 
circulatory exposure of the tissue to inflammatory cells following exercise seems intuitive. As 70 
such, if the temperature of treatment remains physiologically favorable, then duration of 71 
exposure can be extended. It is unknown to what extent prolonged PCM cooling might exert 72 
effects similar to those from CWI. For this reason, it is important to understand the physiological 73 
temperature effects that occur during prolonged PCM cooling and to compare them with a CWI 74 
treatment of matched temperature. Therefore, the purpose of this study was to compare the 75 
physiological effects (muscle, core, skin temperature and HRV) of CWI versus PCM cooling. It 76 
was hypothesized that both CWI and PCM would decrease intramuscular temperature but with a 77 
prolonged effect from PCM due to its ability to deliver a longer cooling duration. 78 
  79 
Methods 80 
Participants 81 
  Eleven active males (mean ± SD; age, 27 ± 6 years; height, 183.6 ± 8.5 cm; body mass, 82 
81.5 ± 12.4 kg) volunteered to participate in this study. All participants were free from lower leg 83 
injury for at least 1 month before the study and had no known vascular disease in the lower 84 
limbs, compromised circulation, allergy or hypersensitivity to cold. Participants were instructed 85 
to refrain from strenuous exercise for 72 h prior to, and for the duration of the study period. The 86 
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institutional ethics committee approved all procedures and participants gave written informed 87 
consent. 88 
Experimental Design 89 
 In this repeated measures, crossover design study participants visited the laboratory on 3 90 
consecutive days. First for a familiarization session before data collection commenced followed 91 
by two separate treatment sessions, all separated by 24 h. Participants were randomized to 92 
receive one treatment on day 1 and the other treatment on day 2. Vastus lateralis muscle 93 
temperature at 1 and 3 cm, skin temperature, core temperature, heart rate (HR), blood pressure 94 
(BP) and thermal comfort were recorded continuously throughout baseline, treatment (15 min 95 
CWI vs 3 h PCM) and recovery (2 h CWI vs 1 h PCM) during both treatments (Figure 1). Data 96 
collection during CWI treatment and recovery consisted of a shorter overall collection period 97 
compared to the PCM trial. Since both treatments were matched for temperature, it was 98 
impractical for participants to remain instrumented for the additional 1 h of recovery following 99 
CWI treatment, in order to match the duration of PCM treatment and recovery. During CWI 100 
treatment (iCool Sport, Australia), participants sat immersed to the umbilicus in an inflatable, 101 
temperature controlled (15 ± 1°C) cold-water bath for 15 min and recovery of all variables was 102 
monitored for 2 h (2 h 15 min total time). During PCM treatment (Glacier Tek; USDA 103 
BioPreferred PureTemp, Plymouth, MN), two PCM blocks (864 cm2 area; 32.4 cm × 2 cm × 104 
13.3 cm) frozen at 15°C were worn over the quadriceps muscles directly on the skin inside 105 
compression shorts (worn up to the knee) for 3 h of treatment, and recovery of all variables was 106 
monitored for 1 h (4 h total time). The PCM packs can maintain a constant temperature of 15°C 107 
for at least 3 h in a thermoneutral environment (as verified by the manufacturer and an 108 
independent quality assurance association, RAL; Quality and Testing Regulations for Phase 109 
Change Materials), until the substance is fully melted.  110 
During data collection, participants remained in a semi-reclined seated position with legs 111 
outstretched on a bed except during the CWI treatment. Upon completion of each treatment, the 112 
dry shorts remained on the participant, while rolled up so that the skin remained exposed, for the 113 
duration of the recovery period. All testing was performed in a temperature-controlled laboratory 114 
(24.9 ± 3.4°C). 115 
 Intramuscular Temperature 116 
 To account for subcutaneous fat, skinfold at the exact site of thermocouple insertion on 117 
the quadriceps was measured using Skinfold Calipers (Harpenden, Baty International, West 118 
Sussex, UK) by the same individual. The vastus lateralis was then marked approximately 6 cm 119 
lateral to the mid-point between the superior pole of the patella and the anterior-superior iliac 120 
crest using a sterile pen. Additional markings were placed 1 cm inferior and superior to this 121 
point, one for each insertion depth. The area was cleaned with a povidone-iodine surgical scrub 122 
solution. Insertion depth was based upon halving the skinfold measure and adding this to the 123 
required depth (1 or 3 cm).  124 
  A 45 and 32 mm sterile intravenous 20 gauge needle catheter was used for the 3 and 1 cm 125 
insertion, respectively. Insertion depth was verified by subtracting the total insertion depth (1 cm 126 
or 3cm plus half the skinfold) from the corresponding length of the needle. The difference 127 
(length of needle minus calculated insertion depth) was verified with a sterile ruler. Once at the 128 
correct insertion depth, the needle was removed and the flexible catheter remained inserted. A 129 
sterile flexible intramuscular Thermocouple Probe (Type T, IT-21; Physitemp Instruments, 130 
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Clifton, NJ) was threaded through the barrel of the catheter. The catheter was removed from the 131 
muscle while the thermocouple remained inserted. The thermocouple insertion site was secured 132 
in place with sterile tegaderm by bending the thermocouple flush with the skin. The procedure 133 
was then repeated for the 1 cm deep thermocouple. Once fully instrumented, the thermocouples 134 
were connected to a digital monitor (Bailey Instruments BAT-12, Physitemp Instruments, Inc) 135 
for continuous recording. Thermocouples remained inserted throughout the duration of treatment 136 
and recovery. At the conclusion of data collection, thermocouples were removed and ‘actual’ 137 
insertion depth was verified by measuring the inserted portion of the thermocouple against a 138 
sterile ruler. The left leg of each subject was instrumented with thermocouples for CWI, while 139 
the right leg of each subject was instrumented for PCM treatment.  140 
Body Temperature and Cardiovascular Measures 141 
Participants were provided with an activated ingestible core temperature sensor 142 
(VitalSense, Respironic Inc, Murrysville, PA, USA) during familiarization. Participants were 143 
instructed to ingest the capsule with water ~8 h prior to initial testing. Participants were given a 144 
second core temperature sensor following completion of testing on day 1 to ingest at the same 145 
time of day as done prior to the first visit.  146 
On arrival to the lab for the treatments, participants were fitted with a wireless 147 
ambulatory chest strap heart rate monitor equipped with a Sensor Electronics Module (SEM; 148 
EQ02 LifeMonitor, Hidalgo Ltd, Cambridge, UK) that continuously recorded heart rate, core, 149 
and skin temperature and with an automated blood pressure cuff on their right arm (M10-IT; 150 
Omron Healthcare). A telemetric dermal patch temperature sensor (VitalSense, Respironic Inc, 151 
Murrysville, PA, USA) was applied to the quadriceps of the leg that was not being instrumented 152 
with intramuscular thermocouples to measure skin temperature.  153 
Heart rate data were analyzed using Vivosense (Vivonoetics, San Diego, USA). 154 
Automatic artifact-marking algorithm was applied to the raw electrocadiogram (sensitivity level: 155 
medium noise filtering; minimal and maximal allowable heart rate limits: 30 and 220 beats per 156 
minutes respectively). R-wave markings were generated for HRV calculations. The square root 157 
of the mean squared differences of successive intervals (RMSSD) is reported. Research suggests 158 
that RMSSD provides the most reliable and practically applicable measure for day-to-day 159 
monitoring.20 Five min rolling averages were calculated for RMSSD, with the baseline measure 160 
taken prior to insertion of the intramuscular thermocouples.  161 
Ratings of thermal comfort were recorded every 15 min. During CWI, thermal comfort 162 
was asked at the first and last minute of immersion. Participants were asked to rate their thermal 163 
comfort on a nine-point standard scale.21   164 
Data Analysis 165 
 Prior to employing ANOVAs, normality of distribution of all data sets was verified using 166 
the Shapiro-Wilk test. Mauchly’s test of sphericity was used to test assumptions of sphericity 167 
and, where necessary, Greenhouse-Giesser corrections were applied. Statistical analyses were 168 
performed using SPSS (v21 IBM, Armonk, NY). The comparison of treatments over time was 169 
assessed using a 2 × 10, treatment by time, repeated measures analyses of variance (ANOVA). 170 
The levels for the treatment factor were group (CWI or PCM) and time (baseline [0 min], and 171 
every 15 min up to 2 h 15 min). For these analyses, the entire duration of CWI treatment (15 172 
min) and recovery (2 h) was compared to the first 2 h 15 min of PCM treatment. Additionally, 173 
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recovery effect (return to baseline) from both treatments over time was assessed using a 2 × 5, 174 
treatment by time repeated measures analyses of variance (ANOVA). The levels for the time 175 
factor were baseline (0 hr), 15, 30, 45 min, 1 h, and 1 h 15 min for CWI and baseline (0 hr), 3 h, 176 
3 h 15 min, 3 h 30 min, 3 h 45 min, and 4 h for PCM. For these analyses, the first 1 h duration of 177 
recovery following each treatment was compared.  Where there was a significant treatment 178 
effect, or treatment by time interaction, differences between treatments at any particular time 179 
interval were assessed using Bonferroni corrections for planned pairwise comparisons. 180 
Within each treatment, the changes in dependent variables over time were assessed by a 181 
one factor ANOVA with differences versus baseline assessed using Bonferroni corrections for 182 
planned pairwise comparisons. Additionally, Pearson product-moment correlation coefficients 183 
were used to assess the relationship between thigh skinfold thickness and intramuscular 184 
temperature. A probability level < 0.05 was accepted to determine significance. All data are 185 
reported as group means ± SD.  186 
 187 
Results 188 
Thermocouple Depth and Skinfold 189 
Skinfolds were 10.1 ± 5.2 mm for the right leg of all participants, and 9.7 ± 5.5 mm for 190 
the left leg. Thermocouple depths, corrected for skinfolds were 3.0 ± 0.4 cm and 1.0 ± 0.3 cm for 191 
PCM and 3.1 ± 0.3 cm and 1.1 ± 0.3 cm for CWI. Decreases in intramuscular temperature were 192 
correlated with skinfold thickness with stronger effects at 1 cm (CWI r = 0.912, P < 0.001; PCM 193 
r = 0.853, P < 0.001) versus at 3 cm (CWI r = 0.727, P < 0.01; PCM r = 0.594, P = 0.05). 194 
Intramuscular Temperature 195 
Intramuscular temperature declined progressively during both treatments (time effect P = 196 
0.0001, Table 1) and remained below baseline at the conclusion of the recovery period (all P < 197 
0.01; Figure 2). CWI decreased intramuscular temperature more rapidly and was 14.0 and 16.1% 198 
lower at end of treatment vs 15 min into PCM treatment at both 1 and 3cm respectively (mean 199 
difference: 4.3 ± 1.7°C at 1 cm and 5.5 ± 2.1°C at 3 cm, both P = 0.01). Intramuscular 200 
temperature remained 10.6% lower 15 min into recovery following the CWI treatment vs 30 min 201 
into PCM treatment at 3 cm (difference: 3.4 ± 1.6°C, P = 0.01) but no longer at 1 cm (2.1%; 202 
difference: 0.6 ± 1.8°C, P = 0.99). Intramuscular temperature at 3 cm was 7.5% higher 203 
(difference: 2.4 ± 2.3°C, P = 0.045; Figure 2) upon conclusion of CWI recovery (2 h 15 min total 204 
time) compared with 2 h 15 min into PCM treatment, while intramuscular temperature at 1 cm 205 
was on average 12.5% higher between CWI vs PCM treatment from 1 h (P = 0.003) to 2 h 15 206 
min (P < 0.001; Figure 2). Over time, intramuscular temperature was lower from PCM treatment 207 
(treatment × time P = 0.0001 at 3 and 1 cm; Figure 2). When comparing intramuscular 208 
temperature for the first 1 h of recovery from both treatments, intramuscular temperature at 1 cm 209 
was 4.1% higher from CWI averaging 28.6 ± 1.4°C than from PCM averaging 27.7 ± 1.7°C 210 
(treatment effect, P = 0.013; Figure 3), with no difference at 3 cm (2.2%; treatment effect P = 211 
0.35; Figure 3).  212 
Core Temperature 213 
Core temperature declined during the PCM and CWI treatments (time effect, P = 0.0001, 214 
Figure 4), with no difference between treatments (treatment × time P = 0.10) (Figure 4). The 215 
nadir of core temperature from PCM treatment occurred 45 min into the recovery period 216 
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(absolute time: 3 h 45 min; 0.28 ± 0.27°C below baseline) while the nadir of core temperature 217 
from CWI treatment occurred 1 h 30 min in to the recovery period (absolute time: 1 h 45 min; 218 
0.25 ± 0.32°C below baseline). 219 
Skin Temperature  220 
Skin temperature declined during both PCM and CWI treatments (time effect, P = 221 
0.0001). CWI decreased skin temperature more rapidly (treatment x time, P = 0.0001) than PCM.  222 
Skin temperature immediately after CWI was 2.4 ± 1.7°C lower than 15 min into the PCM 223 
treatment, however, at all subsequent time points, skin temperature was lower during the PCM 224 
treatment (P < 0.01). During CWI treatment, skin temperature dropped from 31.3 ± 1.1°C at 225 
baseline to 23.6 ± 0.8°C  at 15 min and was 29.5 ± 1.2°C 2 h after CWI. During PCM treatment, 226 
skin temperature averaged 24.1 ± 0.3°C over the 3 h during which subjects wore the PCM and 227 
was 27.7 ± 1.1°C 1 h after removal of PCM.  228 
Perceived Thermal Comfort 229 
 Thermal comfort was significantly different between treatments (treatment × time P = 230 
0.002) with greater thermal discomfort reported immediately post CWI (2.7 ± 0.8 vs. 4.5 ± 0.8 231 
15 min into the PCM treatment, P = 0.01). This time point is also where thermal comfort reached 232 
its nadir for both treatments. Upon conclusion of PCM treatment, thermal comfort was (4.9 ± 233 
1.0). Thermal comfort returned to baseline following 30 min of the recovery period post PCM 234 
treatment.  235 
Cardiovascular Measures 236 
There were technical issues with heart rate signals for 2 participants during the entire 237 
PCM treatment and for one participant after 2 h of the PCM treatment. Thus only 9 participants 238 
were included in the treatment by time analysis of heart rate data and the time analysis only 239 
included data up to 2 h. heart rate declined during both treatments (time effect P = 0.0001) with 240 
no interaction effects (P > 0.05; Table 2). Overall there was an increase in RMSSD during 241 
treatments (Time effect P < 0.0001) with no interaction effect (P = 0.155; Table 2). For the PCM 242 
treatment there was a trend for an increase in RMSSD (Time effect P = 0.069) while for the CWI 243 
treatment there was a clear increase in RMSSD (Time effect P = 0.0001). Blood pressure was 244 
unaffected by either treatment (P = 0.15-0.95) and there were no differences between treatments 245 
(P = 0.62 for systolic, P = 0.84 for diastolic).  246 
 247 
Discussion 248 
 The main finding in this study was that 15 min of CWI was comparable to PCM packs 249 
applied directly to the skin overlying the quadriceps for 3 hours in terms of the magnitude of 250 
reduction in vastus lateralis intramuscular temperature. Ultimately PCM treatment provided a 251 
sustained decrease in intramuscular temperature that was maintained for the 3 h of application 252 
(Figure 2), and a more gradual recovery (Figure 3). However, the initial reduction in 253 
intramuscular temperature was more rapid during the CWI treatment. In addition to the local 254 
effects on muscle temperature, both treatments provided local and systemic effects by decreasing 255 
core temperature, heart rate and increasing HRV. Importantly, the systemic effects were 256 
observed despite there being no exercise intervention to induce cardiovascular stress prior to the 257 
treatments. The combined local and systemic effects likely explain the accelerated recovery from 258 
strenuous exercise that have recently been demonstrated with PCM cooling.7,8 This study 259 
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provides the first evidence that the application of this novel cooling modality, PCM, elicits 260 
comparable physiological effects to those from CWI treatment. 261 
In the present study, average vastus lateralis temperature at 1 cm for the total PCM trial 262 
period (4 h) was 7% lower than the average temperature at 1 cm for the total CWI trial (2 h 15 263 
min).. Thus, not only can PCM provide prolonged cooling, it can also provide a greater 264 
magnitude of cooling to the peripheral musculature. This may have implications for use in 265 
exercise recovery. Since the damage that occurs following strenuous exercise is bimodal, 266 
involving both the initial mechanical and/or metabolic muscle injury and a secondary phase that 267 
involves a disruption in intracellular homeostasis followed by an inflammatory response which  268 
initiates 2-6 hrs post damaging exercise.22 A prolonged cooling intervention during this 269 
timeframe has potential to blunt the inflammatory process that occurs following exercise, thereby 270 
mitigating any additional damage caused by the inflammatory response,18 limiting further 271 
hemorrhage and cell death.22 In support of this rationale, it has previously been demonstrated in 272 
an animal model that local cooling at 8ºC for 6 hrs after closed soft tissue injury limited 273 
subsequent tissue damage.23  274 
 An interesting aspect of the current results is that CWI can induce a rapid drop in muscle 275 
temperature while PCM cooling provides a gradual prolonged decrease in muscle temperature 276 
with a slower rise in muscle temperature at 1 cm during recovery (Figure 3). Therefore, if the 277 
goal is to maximize the tolerable decline in muscle temperature for a sustained period of time, 278 
athletes might opt to combine the treatments. In practice, once an athlete completed a CWI 279 
treatment, quickly decreasing their intramuscular and core temperature, they could apply  PCM 280 
over muscle groups they wish to keep coolin order to maintain the reduction of temperature 281 
while returning to normal post exercise activities (e.g. meal, relaxation, recreational activities). 282 
This could allow the athlete to sustain the treatment effect from CWI for a longer period of time 283 
in the immediate post-exercise period.   284 
The systemic effects observed from PCM cooling in this study are surprising considering 285 
PCM application was localized while CWI involved submerging the lower half of the body. The 286 
longer treatment duration from PCM provided a progressive decline in core temperature so that 287 
ultimately the effects on core temperature and HRV were comparable between treatments. 288 
Previous studies have shown that the rate of core temperature reduction during post-exercise 289 
CWI is dependent on temperature, duration, and the time from the end of exercise to 290 
commencement of CWI treatment.6 However, few studies have examined the impact of CWI on 291 
resting core temperature where there is no exercise-induced temperature elevation prior to CWI 292 
treatment. Costello et al (2012) reported a 0.4 ± 0.2°C reduction in resting rectal temperature 60 293 
min after a 4 min CWI at 8°C with subjects submerged to the sternum. Gregson et al (2011) 294 
reported a 0.2 ± 0.1°C drop in core temperature following two 5 min, 8°C CWI treatments, 295 
separated by 2 min with subjects submerged to the waist. Comparable reductions in core 296 
temperature during treatment were evident in the present study and core temperature remained 297 
depressed for the duration of recovery from both treatments. 298 
In line with the reduction in core temperature, there was a decrease in heart rate and an 299 
increase in HRV, from both treatments. Restoration of cardiovascular homeostasis is an 300 
important component of overall recovery and interventions that increase HRV are thought to be 301 
advantageous to exercise recovery.24 Monitoring indices of HRV has been of increasing interest 302 
among athletes.25 Post-exercise CWI has been shown to accelerate recovery of HRV.15,16 The 303 
present data indicate that CWI and PCM are capable of elevating HRV from a resting condition.  304 
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Since this study did not utilize an exercise intervention prior to the treatments, both the 305 
magnitude and duration of the physiological effects cannot be extrapolated to what might occur 306 
in a post-exercise condition. It remains imperative to mention the paradox between the use of 307 
cryotherapy for acute reduction in inflammation to facilitate recovery and the potential negative 308 
effects that may be caused by blunting the stress response.18 Since some degree of inflammation, 309 
which plays a crucial role in the remodeling and adaptation of skeletal muscle, is required for the 310 
resolution of muscle fiber damage resulting from an exercise insult. However, since the recovery 311 
benefits of CWI have been extensively studied, and preliminarily studies utilizing PCM cooling 312 
with durations between 3-6 h illustrate beneficial effects on recovery of strength, in addition to 313 
soreness,7,8 the present results serve primarily to demonstrate the capacity of both CWI and PCM 314 
cooling to have local and systemic effects. The shorter overall CWI data collection period 315 
compared with PCM data collection complicated the comparisons between treatments. However, 316 
it was not practical to have study participants remain instrumented for an additional 1 h 45 min 317 
following CWI to match the PCM duration, especially since it was a crossover design. A post 318 
CWI duration of 2 h was sufficient to demonstrate the magnitude and duration of effects on 319 
recovery, especially since it has been demonstrated that intramuscular temperature does not 320 
return to baseline for up to 4 h following CWI administered after exercise.26 The 3 h PCM 321 
duration was chosen to replicate the treatment time in field testing,8 and the 1 h recovery time 322 
was deemed sufficient and practical for study participants who were sitting for more than 4 323 
hours. Previous studies have demonstrated that the cooling effect in calf muscles is maintained 324 
for 3-4 h following CWI in normothermic individuals27,28 due to inactivity. Therefore, it was not 325 
feasible to keep study participants instrumented to monitor temperatures that likely would not 326 
have returned to baseline. 327 
This study utilized a cohort of male participants with thigh skinfolds averaging 9.9 ± 5.2 328 
mm., Decreases in intramuscular temperature were correlated with skinfold thickness during 329 
both treatments, due to the insulating effect of adiposity.29,30 It has previously been shown that 330 
body composition influences the magnitude of change in skin, muscle, and core temperature 331 
during and after CWI26. It has also been suggested that muscle mass and its regional distribution, 332 
body surface area to mass ratio, age and ethnicity influence thermal and physiological responses 333 
to water immersion31 Therefore, the results of this study should be cautiously interpreted when 334 
relating them to a more heterogeneous group.  This study should be repeated in a female 335 
population since women generally have greater subcutaneous body fat compared to men, and 336 
because for a given change in body temperature, as occurs during and from exercise, females 337 
require a greater cooling stimulus to maintain thermal comfort levels.32The results from this 338 
study may further differ in a female population due to the added variable of sex hormone-related 339 
fluctuations in body temperature and some thermoregulatory processes during the menstrual 340 
cycle.33 Consequently, the results of this study should be extrapolated with a degree of caution to 341 
the effect of CWI or PCM on intramuscular and core temperature in females, and following 342 
exercise in both genders. Future research should examine PCM application in a more 343 
heterogeneous group as well as following exercise. 344 
Practical Applications 345 
PCM cooling packs applied directly to the skin underneath garments to hold them in 346 
place is an efficacious alternative to CWI, especially if the athlete is seeking a prolonged cooling 347 
exposure. PCM cooling may be more practical than CWI, because individuals can continue with 348 
their activities of daily living while simultaneously receiving a cryotherapy dose.  349 
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Conclusions 350 
This is the first examination of the effect of PCM cooling on intramuscular temperature, 351 
core temperature and cardiovascular function. The magnitude of temperature reduction with 352 
prolonged PCM application was similar to the CWI treatment, but critically, the PCM provided a 353 
sustained cooling effect that was better tolerated than CWI. These physiological effects may 354 
explain the previously reported benefits of PCM cooling in reducing muscle damage in 355 
recreational athletes7 and accelerating recovery in professional soccer players.8   356 
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 440 
Figure 1: Experimental protocol of treatment and recovery during both conditions over time.   441 
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 442 
Figure 2: Vastus lateralis intramuscular temperature. Intramuscular temperature declined 443 
progressively during the PCM treatment (time effect, P < 0.0001) and remained below baseline 444 
after 1:00 of recovery at both depths (P < 0.01). CWI treatment decreased intramuscular 445 
temperature from a baseline to immediately post treatment (time effect, P < 0.0001) and 446 
remained below baseline after 2 h of recovery at both depths (P < 0.01). Intramuscular 447 
temperature was lower with the PCM treatment (treatment x time, P < 0.0001 at 3 and 1 cm). 448 
Intramuscular temperature was lower with CWI vs PCM at 3 cm from 0:00 to 0:30 but only from 449 
0:00 to 0:15 at 1 cm (*, P < 0.01). Intramuscular temperature was lower at 2:15 for PCM vs CWI 450 
treatment at 3 cm and at from 1:00 to 2:15 at 1 cm (‡, P < 0.05).  451 
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 452 
Figure 3: Change in vastus lateralis intramuscular temperature from baseline during recovery. 453 
Recovery time is displayed for the 1 hour immediately following conclusion of both treatments. 454 
Absolute time displayed for CWI is 0:15 through 1:15, and for PCM is 3:00 through 4:00. 455 
Intramuscular temperature was lower (treatment effect, P = 0.013) with PCM vs. CWI at 1 cm (*, 456 
P < 0.05).  457 
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 458 
Figure 4: Mean core temperature of 11 subjects superimposed over the same duration of 459 
treatment and recovery after both PCM and CWI treatment. Core temperature declined during 460 
the PCM and CWI treatments (time effect, P < 0.0001) with no difference between treatments 461 
(treatment x time, P = 0.10). 462 
  463 
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Table 1  A Comparison of Intramuscular Temperatures (1cm and 3cm) during 464 
Baseline, Treatment, and Recovery of the 2 Cryotherapy Treatments (CWI vs PCM), 465 
Mean ± SD 466 
Temperature at 
Protocol Times 
CWI 1cm CWI 3cm PCM 1cm PCM 3cm 
Baseline 34.0 ± 1.1°C 35.6 ± 0.6°C 33.9 ± 1.5°C 35.8 ± 0.5°C 
End of 
Treatment 
26.2 ± 2.9°C 28.4 ± 2.7°C 26.0 ± 2.2°C 28.2 ± 2.8°C 
End of Recovery 30.5 ± 1.0°C*& 31.0 ± 1.0°C* 29.0 ± 1.6°C* 30.1 ± 2.1°C* 
Average 29.4 ± 1.1°C 30.2 ± 1.2°C 27.4 ± 2.1°C$ 29.8 ± 2.4°C 
Intramuscular temperature remained significantly below baseline at the end of recovery for all 467 
conditions (*P < 0.01). Intramuscular temperature during the first hour of recovery was higher 468 
from CWI vs PCM at 1cm (treatment effect, &P = 0.013) but not at 3cm (treatment effect P = 469 
0.35). Average intramuscular temperature at 1cm was significantly lower from PCM treatment 470 
than CWI ($P<0.001) but there was no difference at 3cm (P=0.46).  471 
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Table 2  Fifteen min rolling average HR and RMSSD data during 2 h of PCM 472 
application and 15 min of CWI followed by 1 h 45 min of recovery, Mean ± SD 473 
Time PCM HR CWI HR PCM RMSSD CWI RMSSD 
Baseline 68 ± 7 68 ± 8 60 ± 22 62 ± 30 
0:15 62 ± 9* 61 ± 11 63 ± 24 67 ± 28 
0:30 63 ± 7 61 ± 8 * 61 ± 24 79 ± 25 * 
0:45 64 ± 6 57 ± 8 * 65 ± 22 74 ± 26 
1:00 61 ± 7 * 59 ± 8 * 65 ± 26 70 ± 31 
1:15 62 ± 9 57 ± 8 * 70 ± 26 71 ± 27 
1:30 60 ± 5 * 59 ± 11 75 ± 25 75 ± 31 
1:45 59 ± 7 * 56 ± 9 * 70 ± 25 79 ± 32 
2:00 61 ± 9 57 ± 8 * 73 ± 23 84 ± 33 * 
HR was elevated immediately following CWI treatment (15 min) but was reduced over time 474 
during both treatments (time effect, P < .0001). There was a trend for an increase in RMSSD 475 
during PCM treatment (Time effect, P = 0.069) and a clear increase in RMSSD during and 476 
following CWI (Time effect, P < .0001). * = significant difference from baseline (P < .05) 477 
